Web Images Videos Maps News Shopping Gmail more »
Sign in
Scholar Home  
  Advanced Scholar Search
Scholar Preferences
Scholar Results 1 - 10 of about 101 related to Redmon: One-year outcome of a combination of weight loss therapies for subjects with type 2 diabetes. (0.08 sec) 

One-year outcome of a combination of weight loss therapies for subjects with type 2 …


JB Redmon, SK Raatz, KP Reck, JE Swanson, … - Diabetes Care, 2003 - Am Diabetes Assoc
RESEARCH DESIGN AND METHODS—Overweight or obese individuals with type 2
diabetes treated with diet or oral medication were randomly assigned to either a
standard therapy or combination therapy group. Both groups received a ...
Cited by 52 - Related articles - BL Direct - All 8 versions

Two-year outcome of a combination of weight loss therapies for type 2 diabetes


JB Redmon, KP Reck, SK Raatz, JE Swanson, … - Diabetes Care, 2005 - Am Diabetes Assoc
RESEARCH DESIGN AND METHODS—A total of 59 overweight or obese individuals with
type 2 diabetes were randomly assigned to either a combination therapy weight
loss program for 2 years (C therapy) or a standard therapy weight loss ...
Cited by 25 - Related articles - All 11 versions

[CITATION] the LookAHEAD Research Group. Weight loss intervention of the LookAHEAD Trial: …


D Williamson, T Wadden, D Smith - Int J Obes Relat Metab Disord, 2002
Cited by 6 - Related articles

A randomized trial of sibutramine in the management of obese type 2 diabetic patients …


SJ McNulty, E Ur, G Williams - Diabetes Care, 2003 - Am Diabetes Assoc
RESULTS—Sibutramine induced significant weight loss (P < 0.001) with both 15
mg/day (5.5 ± 0.6 kg at 12 months) and 20 mg/day (8.0 ± 0.9 kg), whereas
placebo did not (0.2 ± 0.5 kg). Weight loss ≥10% was achieved by 14 and ...
Cited by 98 - Related articles - BL Direct - All 6 versions

Pharmacologic induction of weight loss to treat type 2 diabetes.

- diabetesjournals.org [PDF] 
JB Redmon, SK Raatz, CA Kwong, JE … - Diabetes Care, 1999 - Am Diabetes Assoc
F rom the Division of Endocrinology and Diabetes, Department of Medicine,
General Clinical Research Cen- ter, and Division of Biostatistics, School of
Public Health, University of Minnesota, Minneapolis, Minnesota. A dd ress ...
Cited by 35 - Related articles - BL Direct - All 6 versions

[CITATION] Multicenter Sibutramine Study Group. A randomized trial of sibutramine in the management of …


SJ McNulty, E Ur, G Williams - Inpharma, 2003
Cited by 38 - Related articles

Clinical efficacy of orlistat therapy in overweight and obese patients with insulin-treated type …


DE Kelley, GA Bray, FX Pi-Sunyer, S Klein, J … - Diabetes Care, 2002 - Am Diabetes Assoc
OBJECTIVE—Weight loss improves glycemic control, lipid profiles, and blood
pressure in patients with type 2 diabetes. However, successful long-term weight
loss is difficult for these patients, particularly those treated with ...
Cited by 174 - Related articles - BL Direct - All 7 versions

A randomized study of orlistat in combination with a weight management programme in obese …


D Med - Diabet. Med, 2005 - interscience.wiley.com
It is also possible that your web browser is not configured or not able to
display style sheets. In this case, although the visual presentation will be
degraded, the site should continue to be functional. We recommend using the ...
Cited by 25 - Related articles - All 6 versions

Role of sibutramine in the treatment of obese type 2 diabetic patients receiving …


M Serrano-Rios, N Melchionda, E Moreno- … - Diabetic Medicine, 2002 - interscience.wiley.com
It is also possible that your web browser is not configured or not able to
display style sheets. In this case, although the visual presentation will be
degraded, the site should continue to be functional. We recommend using the ...
Cited by 51 - Related articles - BL Direct - All 4 versions

Effect of orlistat in overweight and obese patients with type 2 diabetes treated with metformin


JM Miles, L Leiter, P Hollander, T Wadden, JW … - Diabetes Care, 2002 - Am Diabetes Assoc
RESULTS—After 1 year of treatment, mean (±SE) weight loss was greater in the
orlistat than in the placebo group (−4.6 ± 0.3% vs. −1.7 ± 0.3% of
baseline wt, P < 0.001). Orlistat treatment caused a greater improvement in ...
Cited by 172 - Related articles - BL Direct - All 7 versions


Result Page: 

1

2

3

4

5

6

7

8

9

10

Next


 


Go to Google Home - About Google - About Google Scholar

©2009 Google